
Olmevac-Trio 40/12.5/10 Tablet
Marketer
Prevego Healthcare & Research Private Limited
Salt Composition
Olmesartan Medoxomil (40mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg)
Overview Olmevac-Trio 40/12.5/10 Tablet
Hypertension (high blood pressure) unresponsive to single-drug therapy may be managed with Olmevac-Trio 40/12.5/10mg tablets, a triple-combination medication. This formulation lowers blood pressure, mitigating the risk of stroke and heart attack. Administer Olmevac-Trio with food, at the same time daily, following your physician's prescribed dosage and duration. This medication includes a diuretic; increased urination is expected, therefore avoid dosing within four hours of bedtime. Consistent use, even during symptom-free periods, is crucial, as untreated hypertension is often asymptomatic. Cessation may elevate stroke or heart attack risk. Common side effects include fatigue, headache, altered taste, dizziness, and ankle edema. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to counteract potential side effects such as thirst, dry mouth, and muscle weakness. Prior to initiating treatment, inform your physician of any kidney or liver issues, pregnancy, breastfeeding, or other medications, particularly cardiovascular or antihypertensive agents. Regular monitoring of blood pressure, kidney function, electrolyte balance, and blood glucose is essential to optimize treatment effectiveness.
Primary Ingredients of Olmevac-Trio 40/12.5/10 Tablet
No information provided. Please provide the text you wish me to rewrite.
Uses of Olmevac-Trio 40/12.5/10 Tablet
Elevated blood pressure
Major Benefits of Olmevac-Trio 40/12.5/10 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Olmevac-Trio 40/12.5/10 tablet should be administered with a meal.
Common Side effects of Olmevac-Trio 40/12.5/10 Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Increased blood uric acid
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
How to use Olmevac-Trio 40/12.5/10 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Olmevac-Trio 40/12.5/10 Tablet should be administered with a meal.
How Olmevac-Trio 40/12.5/10 Tablet works:
Olmevac-Trio 40/12.5/10 tablets contain olmesartan medoxomil, cilnidipine, and chlorthalidone, working synergistically to manage hypertension. Olmesartan medoxomil, an angiotensin II receptor antagonist, and cilnidipine, a dihydropyridine calcium channel blocker, both promote vasodilation, reducing blood pressure. Chlorthalidone, a thiazide diuretic, enhances this effect by increasing urinary excretion of sodium and water, contributing to lowered blood pressure and improved vascular function.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Olmevac-Trio 40/12.5/10 tablets and alcohol can result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Use of Olmevac-Trio 40/12.5/10 tablets is contraindicated in pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician may prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Olmevac-Trio 40/12.5/10 tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Olmevac-Trio 40/12.5/10 tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olmevac-Trio 40/12.5/10mg tablets, potentially requiring dose modification. Physician consultation is advised. This medication is generally contraindicated in such cases.
LiverCAUTION
Patients with liver impairment should use Olmevac-Trio 40/12.5/10 Tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Olmevac-Trio 40/12.5/10 Tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Olmevac-Trio 40/12.5/10 Tablet :
Should you forget to take a scheduled Olmevac-Trio 40/12.5/10 Tablet, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmevac-Trio 40/12.5/10 Tablet
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Heart |
